These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 16920287)

  • 1. Mixing time effects on the dispersion performance of adhesive mixtures for inhalation.
    Grasmeijer F; Hagedoorn P; Frijlink HW; de Boer HA
    PLoS One; 2013; 8(7):e69263. PubMed ID: 23844256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of drug load on the aerosolisation propensity of binary adhesive mixtures for inhalation.
    Simonsson A; Bramer T; Wimbush A; Alderborn G
    Int J Pharm; 2024 May; 657():124122. PubMed ID: 38621619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porous Lactose as a Novel Ingredient Carrier for the Improvement of Quercetin Solubility
    Liu W; Wang TT; Tang XL; Jiang FY; Yan X; Deng J
    Bioinorg Chem Appl; 2021; 2021():2586990. PubMed ID: 34490051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review on physical and chemical factors affecting fines migration in porous media.
    Yang Y; Yuan W; Hou J; You Z
    Water Res; 2022 May; 214():118172. PubMed ID: 35196620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine excipient materials in carrier-based dry powder inhalation formulations: The interplay of particle size and concentration effects.
    Elsayed MMA; Alfagih IM; Brockbank K; Alheibshy F; Aodah AH; Ali R; Almansour K; Shalash AO
    Int J Pharm X; 2024 Jun; 7():100251. PubMed ID: 38799178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Carrier Performance in Low-Dose Dry Powder Inhalation: An In Vitro
    Pinto JT; Cachola I; F Pinto J; Paudel A
    Pharmaceutics; 2021 Feb; 13(3):. PubMed ID: 33668317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of physical properties of carrier on the performance of dry powder inhalers.
    Peng T; Lin S; Niu B; Wang X; Huang Y; Zhang X; Li G; Pan X; Wu C
    Acta Pharm Sin B; 2016 Jul; 6(4):308-18. PubMed ID: 27471671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New mechanisms to explain the effects of added lactose fines on the dispersion performance of adhesive mixtures for inhalation.
    Grasmeijer F; Lexmond AJ; van den Noort M; Hagedoorn P; Hickey AJ; Frijlink HW; de Boer AH
    PLoS One; 2014; 9(1):e87825. PubMed ID: 24489969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of solvent treatment on the performance of various carriers in dry powder inhalations containing salbutamol sulphate.
    Siahai Shadbad MR; Millen L; Momin M; Nokhodchi A
    Iran J Basic Med Sci; 2013 Jul; 16(7):873-81. PubMed ID: 23997919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?
    de Boer AH; Chan HK; Price R
    Adv Drug Deliv Rev; 2012 Mar; 64(3):257-74. PubMed ID: 21565232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactose characteristics and the generation of the aerosol.
    Pilcer G; Wauthoz N; Amighi K
    Adv Drug Deliv Rev; 2012 Mar; 64(3):233-56. PubMed ID: 21616107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.
    Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
    Int J Pharm; 2006 Dec; 327(1-2):17-25. PubMed ID: 16920287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Kussendrager KD; Frijlink HW
    Int J Pharm; 2003 Jul; 260(2):201-16. PubMed ID: 12842340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation.
    Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
    Eur J Pharm Biopharm; 2005 Jan; 59(1):197-205. PubMed ID: 15567318
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.